Ubs Group Ag Procept Bio Robotics Corp Transaction History
Ubs Group Ag
- $528 Billion
- Q1 2025
A detailed history of Ubs Group Ag transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Ubs Group Ag holds 211,600 shares of PRCT stock, worth $12 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
211,600
Previous 154,113
37.3%
Holding current value
$12 Million
Previous $12.4 Million
0.66%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding PRCT
# of Institutions
301Shares Held
41.9MCall Options Held
293KPut Options Held
141K-
Vanguard Group Inc Valley Forge, PA5.13MShares$290 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$197 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY2.14MShares$121 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.42MShares$80.1 Million0.05% of portfolio
-
State Street Corp Boston, MA1.19MShares$67.2 Million0.0% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $2.52B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...